SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms Inc. is experiencing a sharp sell-off as investors react to unfavorable court rulings regarding addictive content and rising concerns over heavy AI capital expenditure. The community is actively debating whether this decline represents a major buying opportunity due to strong fundamentals or a deeper structural shift in social media regulation.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to volatility driven by reports of Google's new memory compression technology, which some fear could reduce future demand for traditional memory chips. The community remains deeply divided, with many bulls highlighting the company's strong fundamentals and critical role in the AI supply chain, while others are caught in a broader market sell-off triggered by geopolitical tensions and concerns over cyclicality.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is experiencing extreme volatility as traders grapple with escalating geopolitical tensions and erratic energy markets, fueling intense community debate over whether to buy the dip or prepare for further downside. Investors are closely monitoring potential diplomatic developments regarding the Strait of Hormuz, with the discourse split between those aggressively scalping the swings and others cautioning that leveraged semi-conductor exposure remains a risky play amidst broader economic uncertainty.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing renewed positive momentum driven by a strategic ad partnership with Pacvue that expands its enterprise-scale advertising capabilities. Investors are closely watching ongoing insider buying, which appears to be tempering concerns surrounding previous executive stock sales.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining momentum as investors eye its dual GLP-1/GIP agonist, VK2735, as a high-potential challenger in the multibillion-dollar obesity market. The community remains focused on upcoming trial milestones, viewing the stock as a prime acquisition target due to its clinical progress and clean profile relative to competitors.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is seeing heightened investor attention and a strong upward trend, driven by robust commercial execution of its lead therapy, Rezdiffra, and speculation regarding potential long-term acquisition interest from major biopharma players. While the community is actively debating the company's high operating expenses versus its market leadership in the MASH space, technical momentum and positive analyst coverage continue to fuel significant bullish sentiment.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is surging after the GLOW2 Phase 3 study for its eye drug, Zenkuda, met primary endpoints with superior results compared to sham treatment. The community is actively discussing a potential short squeeze due to high short interest, while debating whether the current move marks a long-term rerating of the company's platform or a temporary spike prone to profit-taking.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is experiencing heightened market attention following a volatile reaction to interim clinical data for its obesity candidate, WVE-007, which has sparked intense debate over its long-term potential compared to GLP-1 incumbents. While some investors are bullish on the company's RNA-based platform and its unique ability to reduce visceral fat while preserving muscle mass, others remain skeptical about the trial design and are wary of potential further downside as analysts balance ambitious price targets against the challenges of a crowded obesity pipeline.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV investors are reacting negatively to a recent reverse stock split, with many in the community expressing extreme frustration over a lack of communication from management and a sharp decline in share price. Discussion is dominated by concerns over the company's long-term viability, allegations of market manipulation, and intense debate regarding whether the stock is an oversold buying opportunity or a value trap heading toward bankruptcy.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with concerns over high AI capital expenditures and a potential slowdown in software revenue growth, leading to a persistent decline in share price. The community is deeply divided between those viewing the current drop as an oversold, generational buying opportunity and those fearing a deeper structural breakdown in the stock's long-term momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

180 Life Sciences Corp, which is rebranding as ETHZilla, drew heavy retail interest on Tuesday after revealing that it holds $349 million worth of Ethereum and about $238 million in cash equivalents, alongside a recent 7.5% stake disclosure from billionaire investor Peter Thiel.The stock more than tripled to $6.9 on Tuesday, hitting a 10-month high, and added another 6.7% in after-hours trading.The company stated that it owns 82,186 Ether (ETH) at an average purchase price of $3,806.71, with recent acquisitions intended for long-term holding and staking through Electric Capital’s proprietary strategies, which aim to generate yield.&nbsp;Executive Chairman McAndrew Rudisill said more than $350 million had been deployed since closing a $425 million private investment in public equity (PIPE) deal last week.ETHZilla’s treasury strategy is based on plans announced on July 29 to make Ether its principal reserve asset, managed through an on-chain yield generation program designed to outperform traditional ETH staking.&nbsp;The PIPE deal drew more than 60 institutional and crypto-native investors, including Electric Capital, Polychain Capital, GSR, and Ethereum ecosystem founders such as Konstantin Lomashuk, Sreeram Kannan, and Robert Leshner.The Palo Alto-based company said its DeFi Council, comprising capital markets veterans, engineers, and protocol founders, will advise on strategies that combine staking, lending, liquidity provision, and private agreements.&nbsp;ETHZilla stated that it aims to establish itself as a benchmark for on-chain treasury management among public companies.In a regulatory filing with the U.S. Securities and Exchange Commission&nbsp;late Monday, Thiel reported beneficial ownership of 11.6 million shares, or 7.5% of ETHZilla, through entities linked to his Founders Fund.Originally a biotechnology company, 180 Life Sciences is shifting toward Ethereum-focused treasury management, software-enabled gaming, and entertainment, while seeking to monetize its legacy biotech assets.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 2,363% surge in 24-hour message volume.One user noted that traders who bought $ATNF warrants had seen outsized gains, attributing the rally largely to Ethereum’s strength and calling crypto treasury plays “hot” across multiple tickers.<stembedurl>https://stocktwits.com/CCTVon/message/624880257</stembedurl>Another user pointed out that $ATNF was now another Ethereum treasury company with backing from Peter Thiel, who had also invested in $BMNR, and said they planned to take a position.<stembedurl>https://stocktwits.com/moonstocks777/message/624875436</stembedurl>180 Life Sciences’ stock has risen nearly 463% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration of the ethereum cryptocurrency 'altcoin' sits arranged for a photograph on April 25, 2018 in London, England. (Photo by Jack Taylor/Getty Images)

This Small-Cap Life Sciences Stock More Than Tripled, Thanks To An Ethereum Pivot And Peter Thiel

180 Life Sciences, set to rebrand as ETHZilla, revealed a $349 million Ethereum reserve, a staking plan with Electric Capital, and a 7.5% stake from Peter Thiel’s Founders Fund.

Equity

180 Life Sciences (ATNF) 180 Life Sciences surged more than 500% on Wednesday becoming the top gainer across U.S. exchanges, boosting retail sentiment.The <a href="https://stocktwits.com/news-articles/markets/equity/atnf-stock-surges-on-online-gaming-pivot/cJcz40JRIG">sharp rally</a> followed the company’s announcement of its strategic pivot into online gaming, or iGaming, a move that seems to have sent retail investors into a frenzy.Retail sentiment on Stocktwits has skyrocketed to ‘extremely bullish’ (97/100) from ‘neutral’ a day ago.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_223155_cd82ae123f.png" alt="Screenshot 2024-10-16 223155.png">NuScale Power Corp. (SMR)NuScale Power shares surged 33% on Wednesday, buoyed by <a href="https://stocktwits.com/news-articles/markets/equity/amazon-signs-agreements-to-support-nuclear-energy-development/cJcza0dRIc">Amazon's decision</a> to invest in nuclear energy to power its data centers and other facilities at its Washington state headquarters.NuScale specializes in small modular reactors (SMRs), the same cutting-edge technology Amazon is considering to meet its growing energy demands. The stock soared to an all-time high of $18.01, marking a remarkable 473% year-to-date increase.Retail sentiment on Stocktwits has dramatically shifted, moving from 'bearish' to 'extremely bullish' (97/100) within a day.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_225310_41cad3a0dc.png" alt="Screenshot 2024-10-16 225310.png">Korro Bio (KRRO)Korro Bio's shares skyrocketed 111% on Wednesday following Wave Life Sciences’ <a href="https://stocktwits.com/news-articles/markets/equity/wave-life-sciences-stock-surges-on-rna-editing-breakthrough/cJczOOPRI5">announcement</a> of early validation for its latest RNA editing technology, a promising breakthrough in the field of genetic medicine.Korro Bio is heavily investing in RNA editing therapies, specifically targeting Alpha-1 Antitrypsin Deficiency (AATD). The company plans to seek regulatory approval by the end of the year to begin clinical trials for its RNA editing treatments.Retail sentiment around the company on Stocktwits has been initiated at ‘extremely bullish’ (97/100).<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_16_231152_5247ea7ca2.png" alt="Screenshot 2024-10-16 231152.png">For updates and corrections email newsroom@stocktwits.com.Read more:<a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-falls-after-robotaxi-event-underwhelms/cJcVcLcR4T">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/abbott-labs-stock-dips-pre-market-on-narrowed-profit-outlook-retail-turns-bearish/cJcz2u7R4D">Abbott Labs Stock Dips Pre-Market On Narrowed Profit Outlook: Retail Turns Bearish</a>

Rising stock prices of 180 Life Sciences, Korro Bio, and NuScale Power fuel bullish retail sentiment on Stocktwits

180 Life Sciences, Korro Bio, NuScale Power: Retail Investors Turn Most Bullish On These Stocks

Small-cap stocks like Korro Bio and NuScale Power are benefiting from the momentum generated by larger stocks.

Shares of 180 Life Sciences Corp. (<a class="mention" data-mention="$ATNF" data-symbol-id="ATNF" href="https://stocktwits.com/symbol/ATNF" target="_blank">$ATNF</a>) surged more than 500% on Wednesday, becoming the top gainer across U.S. exchanges, boosting retail sentiment.The sharp rally followed the company’s announcement of its strategic pivot into online gaming, or iGaming, a move that has sent retail investors into a frenzy.In a letter to shareholders, interim CEO Blair Jordan revealed that 180 Life Sciences plans to enter the global iGaming market using a newly acquired blockchain-based gaming platform, which supports cryptocurrency transactions.Initially, the company will focus on B2C online casinos, with plans to expand into a B2B model that will provide blockchain-enabled technology solutions to gaming operators worldwide.180 Life highlighted that it sees attractive acquisition opportunities within the iGaming industry, leveraging the company’s Nasdaq listing to consolidate private gaming firms.“We hope that this liquidity advantage will allow 180 to acquire private gaming companies at attractive valuations,” the company stated, though no immediate acquisitions are planned as it continues conducting preliminary diligence.<figure class="image"><a href="https://stocktwits.com/symbol/ATNF"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ATNF_sentiment_and_message_volume_Oct_16_2024_910b66e22e.png" alt="ATNF sentiment and message volume Oct 16 2024.png" width="1314" height="320"></a><figcaption>ATNF sentiment and message volume Oct 16 2024 as of 10:45 am ET | source: Stocktwits</figcaption></figure>Retail investors responded enthusiastically on Stocktwits, where sentiment shifted to ‘extremely bullish’ (97/100) from ‘neutral’ just a day prior.<stembedurl>https://stocktwits.com/JJ353/message/589101640</stembedurl><stembedurl>https://stocktwits.com/evanevans/message/589087909</stembedurl>180 Life Sciences confirmed last week that it had regained compliance with Nasdaq’s minimum stockholders’ equity requirement, a crucial step that enables it to focus on its iGaming expansion while continuing to advance its biotechnology programs.Earlier this month, the company reported progress on its synthetic CBD analogs (SCAs), designed as safer, more effective alternatives to unregulated CBD products.Year-to-date, the stock is up more than 165%. The company's current market cap is under a million dollars.Read next: <a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-falls-after-fda-clinical-hold-on-vaccine-candidates/cJczdHnR4y">Novavax Stock Tanks After FDA’s Clinical Hold On Vaccine Candidates: Retail Turns Jittery</a> &nbsp;

These stocks hit a new 52-week high today

180 Life Sciences Turns Retail Heads With Online Gaming Entry, Stock Surges 500% 

Interim CEO Blair Jordan revealed that 180 Life Sciences plans to enter the global iGaming market using a newly acquired blockchain-based gaming platform, which supports cryptocurrency transactions.

Forum Markets, Inc. is a technology company in the decentralized finance (DeFi) industry, which intends to connect financial institutions, businesses, and organizations worldwide by enabling secure, accessible blockchain transactions through Ethereum Network protocol implementations. It continues to maintain the deployment and development of its biotech and gaming operations. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

ATNF
180 Life Sciences Corp

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ATNF News

ATNF180 Life Sciences Corp